Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Biomicrogen
    Junior Member
    • Aug 2012
    • 6

    #1

    RNA-SEQ, Gene duplication, and gauging system regulation

    Hi All!

    So I have a few questions here:

    I am comparing gene expression between two lifestyles of a novel organism, which I have a draft annotated genome for. There appears to be several copies of many different genes distributed at various loci on the genome, this could be an assembly artifact but I'm not inclined to believe that as the genomic context around most of the duplicated genes is different.

    1) If I have several annotated "copies" of a gene which my transcripts map to, and say there is variation in the Log2 fold levels of each (some up some down, all significant) of the "copies", can I add these numbers to get an overall expression change of this one gene if I think it is a duplicate? However, perhaps this is a biologically relevant change than by doing this I would loose valuable information.

    2) Along these same lines, if I am looking at a system, say CDS involved in photosystem I, would it be biologically relevant to add all the fold changes of all genes in this system and say that Photosytem I is generally X fold ip/down regulated?? It seems a fairly straightforward assumption but perhaps I am missing somethiing?
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    1) Sure, I've used the same trick with other transcripts that happen to appear multiple times in the genome.
    2) No, that's not legit. What you're looking for there is called "pathway analysis", though it won't give you a fold enrichment (if you needed that, you might just report the median change, though that is itself not without issues).

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    39 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...